Tetrahydrofuran → HCID 51003629, compound
Reaction equation
Br[C:2]1[CH:31]=[CH:30][C:5]([O:6][CH2:7][CH2:8][CH2:9][N:10]2[CH2:15][CH2:14][CH:13]([C:16]([C:24]3[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=3)([C:18]3[CH:23]=[CH:22][CH:21]=[CH:20][CH:19]=3)[OH:17])[CH2:12][CH2:11]2)=[CH:4][CH:3]=1.[N:32]1[CH:37]=[CH:36][C:35](B(O)O)=[CH:34][CH:33]=1.C1COCC1>C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.Cl[Pd]Cl.[Fe+2].O>[C:18]1([C:16]([C:24]2[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=2)([CH:13]2[CH2:14][CH2:15][N:10]([CH2:9][CH2:8][CH2:7][O:6][C:5]3[CH:30]=[CH:31][C:2]([C:35]4[CH:36]=[CH:37][N:32]=[CH:33][CH:34]=4)=[CH:3][CH:4]=3)[CH2:11][CH2:12]2)[OH:17])[CH:23]=[CH:22][CH:21]=[CH:20][CH:19]=1Participants
6
Reactant 3
Product 1
Reagents, catalysts & solvents 2
Conditions
- Temperature
- 90 °C
Procedure
Bromide intermediate (1-(3-(4-bromophenoxy)propyl)piperidin-4-yl)diphenylmethanol (A1) (75 mg, 0.15 mmol), Pd(dppf)Cl2 (15 mg), CsCO3 (150 mg), and pyridin-4-ylboronic acid (30 mg) was placed under an argon atmosphere in a microwave vial. Degassed THF (3 mL) and 0.1 mL of water was added via syringe and the mixture heated for 30 min. at 90° C. in a Biotage microwave reactor. The reaction was partitioned between EtOAc (10 mL) and water (3 mL) and the organic phase isolated. The organic phase was subsequently washed with brine, dried over Na2SO4, and concentrated to dryness. Purification by RP-HPLC afforded the title compound (30 mg, 41%): LC-MS (>98%) m/z=479.1 [M+H].
Workup
- customThe reaction was partitioned between EtOAc (10 mL) and water (3 mL)
- customthe organic phase isolated
- washThe organic phase was subsequently washed with brine
- dry with materialdried over Na2SO4
- concentrationconcentrated to dryness
- customPurification by RP-HPLC
Sources & evidence
- ORD record
- ord-67e90d5eb00744ca93c9cf7c9ba05f59
- Source dataset
- uspto-grants-2015_12
- Patent number
- US09212180B2
Reaction notes
Loading…